Treatment and outcome of 14 children with hepatoblastoma.
- Author:
Ting WEI
1
;
Ti-Quan YANG
;
Yi-Ge LUO
;
Chun-Qiang DONG
Author Information
- Publication Type:Journal Article
- MeSH: Chemoembolization, Therapeutic; Child; Child, Preschool; Combined Modality Therapy; Female; Hepatoblastoma; blood; therapy; Humans; Infant; Lung Neoplasms; blood; therapy; Male; Retrospective Studies; Treatment Outcome; alpha-Fetoproteins; analysis
- From: Chinese Journal of Contemporary Pediatrics 2009;11(6):456-459
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo assess the outcome of childhood hepatoblastoma after a combination therapy of resection and chemotherapy.
METHODSThe clinical data of 14 children with hepatoblastoma was retrospectively reviewed. Their long-term survival was followed-up.
RESULTSTwelve cases received surgery and planned chemotherapy. The follow-up duration averaged 18 months (range 1.5-74 months). Nine survived free of events, 1 died, 1 survived with multiple lung metastases, and 1 with increased alpha-fetoprotein (AFP) content but without residual tumor.
CONCLUSIONSSurgery assisted with chemotherapy can improve the outcome of hepatoblastoma.
